MedTrace Logo

GastrOesophageal Tumor, Immune Microenvionnment (GOTIM)

NCT05644431 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2023-08-30

No results posted yet for this study

Summary

This trial is a prospective, monocentric, non-therapeutic, interventional cohort study aiming to decipher the immune TME through standard neoadjuvant CT in resectable G/GEJ adenocarcinomas. This study will also longitudinally monitor MRD during neoadjuvant and adjuvant therapy.

Conditions

Sponsors & Collaborators

  • Centre Leon Berard

    lead OTHER

Principal Investigators

  • Clélia COUTZAC, MD · Centre Leon Berard

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-19
Primary Completion
2028-01-15
Completion
2028-01-15

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05644431 on ClinicalTrials.gov